Amgen, Inc. (AMGN) declared a partnershipwith Roche on a Phase 1b study to evaluate the safety and efficacy of talimogene laherparepvec, Amgen’s investigational oncolytic immunotherapy, in combination with Roche’s investigational anti-PDL1 therapy, atezolizumab (also known as MPDL3280A), in patients with triple-negative breast cancer and colorectal cancer with liver metastases.

Talimogene laherparepvec is an investigational oncolytic immunotherapy designed to selectively replicate in tumors (but not normal tissue) and to initiate an immune response to target cancer cells. Atezolizumab is an investigational monoclonal antibody designed to interfere with the PD-L1 protein.

The rationale for combining these two investigational agents is to activate an anti-tumor immune response with talimogene laherparepvec and to block inhibitory T cell checkpoints with atezolizumab, to potentially enhance the anti-tumor activity relative to each agent alone.

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.

TJX Companies Inc (NYSE:TJX)’s shares dropped -0.31% to $64.89.

TJX Companies Inc (TJX) declared sales and earnings results for the first quarter ended May 2, 2015. Net sales for the first quarter of Fiscal 2016 raised 6% to $6.9 billion, and merged comparable store sales raised 5%. Net income for the first quarter was $475 million, and diluted earnings per share were $.69, an 8% enhance over the prior year.

Carol Meyrowitz, Chief Executive Officer of The TJX Companies, Inc., stated, “We are extremely happy with our continued momentum and first quarter performance. Our 5% merged comparable store sales growth and 8% enhance in earnings per share were both well above our plan. Our outstanding values and exciting mix of apparel and home fashions continue to resonate with shoppers across all of our geographies. It was great to see that, similar to last quarter, comp sales were almost entirely driven by customer traffic and we had a noteworthyenhance in units sold. At the same time, we also saw a strong enhance in our merchandise margins. We were very happy that we achieved these strong results despite noteworthyforeign currency headwinds and while simultaneously investing in our business to support our growth aims. Our underlying business remains strong, our values are better than ever, and we have many exciting initiatives planned for the remainder of the year to continue driving sales and customer traffic. Further, we are thrilled to see our retail brands becoming more powerful and recognizable with consumers. We are raising our full year earnings per share and comp sales guidance based on the strength of our first quarter results. The second quarter is off to a very strong start and we are confident in our ability to achieve our plans for 2015. We remain convinced that we have the right strategy in place to achieve our long-term growth aims as TJX continues on the path to becoming a $40 billion-plus global, value retailer!”

The TJX Companies, Inc. operates as an off-price apparel and home fashions retailer in the United States and internationally. It operates through four segments: Marmaxx, HomeGoods, TJX Canada, and TJX Europe. The company sells family apparel, counting footwear and accessories; home fashions, such as home basics, accent furniture, lamps, rugs, wall décor, decorative accessories, and giftware; and other merchandise. It operates stores under the T.J. Maxx, Marshalls, HomeGoods, Winners, HomeSense, T.K. Maxx, and Sierra Trading Post names, in addition to operates e-commerce sites tjmaxx.com, tkmaxx.com, and sierratradingpost.com.

At the end of Tuesday’s trade, Humana Inc (NYSE:HUM)‘s shares dipped -0.08% to $214.74.

Humana Inc (HUM) declared recently that it has accomplished its formerly declared sale of the stock of its wholly-owned partner, Concentra Inc. (Concentra), to MJ Acquisition Corporation for about $1.055 billion in cash, subject to customary adjustments. MJ Acquisition Corporation is a joint venture between Select Medical Holdings Corporation (SEM), a leading operator of specialty hospitals and outpatient rehabilitation clinics in the U.S., and Welsh, Carson, Anderson & Stowe XII, L.P., a private equity fund.

The divestiture of Concentra demonstrates the company’s commitment to its formerly declared business portfolio review, ensuring each business supports the company’s integrated care delivery strategy and earns the appropriate return on invested capital.

As formerly revealed, Humana anticipates recognition of a one-time gain from the sale of Concentra during the year ending December 31, 2015 in the range of $1.35 to $1.45 per share, counting the $0.35 per share tax benefit recognized in the quarter ended March 31, 2015 related to the then pending sale.

Humana Inc., together with its auxiliaries, operates as a health and well-being company. The company operates through three segments: Retail, Employer Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, counting dental, vision, and other supplemental health and financial protection products directly to individuals.

Graphic Packaging Holding Company (GPK) Board of Directors declared a quarterly dividend of $0.05 per share. The dividend is payable on July 5, 2015 to shareholders of record at the close of business on June 15, 2015.

Graphic Packaging Holding Company, together with its auxiliaries, provides paper-based packaging solutions to food, beverage, and other consumer products companies. The company produces a range of paperboard grades convertible into folding cartons primarily to protect products, such as food, detergents, paper products, beverages, and health and beauty aids. It also designs, manufactures, and installs packaging machinery related to the assembly of cartons; and produces and sells corrugated medium and kraft papers.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

On Monday, Shares of Energy Transfer Equity LP (NYSE:ETE), lost -3.38% to $19.43.

Energy Transfer Equity, and Energy Transfer Partners, declared that effective recently, Marshall (Mackie) S. McCrea, formerly President and Chief Operating Officer of ETP, has been promoted to Group Chief Operating Officer and Chief Commercial Officer for ETE. Also effective recently is the appointment of long-time ETE board member, Matthew S. Ramsey as President and Chief Operating Officer of ETP.

In his new role, Mr. McCrea, who has been instrumental in ETP’s success, is responsible for the oversight and development of all commercial and planned opportunities for the entire family of midstream partnerships. Preceding to his appointment as ETP president in 2008, McCrea held a number of senior administration positions within the partnership counting President of Energy Transfer Company, a partner of ETP, and Senior Vice President of business development. McCrea began his career in the energy industry in 1983.

Energy Transfer Equity, L.P., through its auxiliaries, provides diversified energy-related services in the Unites States. It owns and operates about 7,700 miles of natural gas transportation pipelines and 3 natural gas storage facilities located in the state of Texas; and about 12,800 miles of interstate natural gas pipeline.

Shares of L Brands Inc (NYSE:LB), declined -3.31% to $93.67, during its last trading session.

L Brands, declared the declaration of its regular quarterly dividend of $0.50 per share payable on Dec. 4, 2015, to shareholders of record at the close of business on Nov. 20, 2015. This is the company’s 164th successive quarterly dividend.

L Brands, Inc. operates as a specialty retailer of women’s intimate and other apparel, beauty and personal care products, and accessories. The company operates in three segments: Victoria’s Secret, Bath & Body Works, and Victoria’s Secret and Bath & Body Works International.

Finally, Shares of CF Industries Holdings, Inc. (NYSE:CF), ended its last trade with 3.61% gain, and closed at $48.20.

Shares of Chico’s FAS, Inc. (NYSE:CHS), inclined 0.07% to $14.98, during its current trading session.

ServiceMaster Global Holdings, Inc. (SERV), a leading provider of essential residential and commercial services, recently declared preliminary unaudited second-quarter 2015 results. The company stated second-quarter 2015 revenue of $716 million, an enhance of 5 percent contrast to the same period in 2014. The enhance in revenue was driven by strong organic growth at American Home Shield (“AHS”), raised sales of new services at Terminix and price enhances, partially offset by lower demand for traditional termite services.

The company stated second-quarter 2015 net income of $67 million or $0.49 per share, counting a loss on extinguishment of debt of $14 million related to the company’s redemption of its 8% Senior Notes, as compared to $40 million or $0.44 per share in the same period in 2014.

The company stated second-quarter 2015 adjusted net income of $82 million, or $0.60 per share, as compared to $52 million, or $0.56 per share, for the same period in 2014. Earnings per share and other share data contained in this release reflect 136.5 million and 92.2 million diluted share counts for the second quarter ended June 30, 2015 and 2014, respectively.

GNC Holdings, Inc. (GNC) a leading global specialty health, wellness and performance retailer, recently declared its Board of Directors has authorized a multi-year program to repurchase up to an aggregate $500 million of the Company’s Class A common stock. The authorization is effective right away, and is in addition to the Company’s previous authorization which presently has $242.0 million remaining. The Company may finance any repurchases with cash, potential financing transactions, or a combination of the foregoing. The repurchases are predictable to take place over the next 24 months with the amount and timing determined by the Company based on its financial condition, business opportunities and the market conditions at the time.

GNC Holdings, Inc. operates as a specialty retailer of health and wellness products. The company operates through three segments: Retail, Franchise, and Manufacturing/Wholesale. Its products comprise vitamins, minerals and herbal supplements, sports nutrition products, diet products, and other wellness products. The company sells its products under GNC proprietary brands, counting Mega Men, Ultra Mega, Total Lean, Pro Performance, Pro Performance AMP, Beyond Raw, GNC Puredge, GNC GenetixHD, and Herbal Plus, in addition to under third-party brands. It operates a network of about 8,900 locations worldwide.

Omega Healthcare Investors, Inc. (OHI) (declared its results of operations for the three-month period ended June 30, 2015. The Company also stated for the three-month period ended June 30, 2015 Funds From Operations (“FFO”) accessible to common stockholders of $100.7 million or $0.52 per common share and Funds Accessible For Distribution (“FAD”) to common stockholders of $136.1 million or $0.70 per common share.

GAAP NET INCOME

For the three-month period ended June 30, 2015, the Company stated net income of $43.5 million, or $0.22 per diluted common share, on operating revenues of $197.7 million. This compares to net income of $46.8 million, or $0.37 per diluted common share, on operating revenues of $121.8 million, for the same period in 2014.

For the six-month period ended June 30, 2015, the Company stated net income of $86.5 million, or $0.53 per diluted common share, on operating revenues of $331.1 million. This compares to net income of $102.6 million, or $0.81 per diluted common share, on operating revenues of $242.8 million, for the same period in 2014.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. was founded in 1992 and is based in Maryland, United States.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.

On Thursday, Shares of Century link Inc (NYSE:CTL), lost -0.91% to $25.16.

Century Link, Inc. (CTL) plans to release its fourth quarter 2015 earnings results after the market closes on Wednesday, February 10, 2016, and host a related conference call at 4:00 p.m. CST that day.

KBC Group reduced its position in shares of Centurylink Inc (NYSE:CTL) by 39.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 273,559 shares of the company’s stock after selling 180,426 shares during the period. KBC Group’s holdings in Centurylink were worth $6,871,000 as of its most recent filing with the SEC.

Separately, ING Groep raised its position in Centurylink by 84.3% in the third quarter. ING Groep now owns 1,029,412 shares of the company’s stock worth $25,849,000 after buying an additional 470,870 shares in the last quarter.

Century Link, Inc. provides various communications services to residential, business, governmental, and wholesale customers in the United States. It operates through two segments, Business and Consumer. The company offers broadband services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; private line services for transmission of large amounts of data between sites; and multi-protocol label switching, a data networking technology to support real-time voice and video.

Shares of Valero Energy Corporation (NYSE:VLO), declined -1.19% to $70.73, during its last trading session.

Valero Energy Corporation operates as an independent petroleum refining and marketing company in the United States, Canada, the Caribbean, the United Kingdom, and Ireland. It operates through two segments, Refining and Ethanol. The Refining segment is involved in refining, wholesale marketing, and product supply and distribution, and transportation operations.

Finally, Willis Group Holdings PLC (NYSE:WSH), ended its last trade with -0.73% loss, and closed at $48.58.

Willis Group Holdings plc (WSH), the global risk advisory, re/insurance broking, and human capital and benefits firm, has declared the completion of its acquisition of Gras Savoye, the leading French insurance broker.

On April 22, 2015, Willis Group declared a firm offer to acquire the remaining 70 per cent of Gras Savoye that it did not own. The transaction accomplished on December 29, 2015, following acceptance of the offer by Gras Savoye shareholders in late June, consultation with workers’ councils, and the receipt of regulatory approvals.

Willis and Gras Savoye will work together to bring the best of their organisations to clients, enabling them to innovate and implement the /files/includes/todays-hot-stories-pfizer-nysepfe-emc-corporation-nyseemc-att-nyset-spirit-realty-capital-nysesrc-154687-right.js solutions to manage risk and people.

Blue Calypso, Inc. developer of patented mobile consumer shopping engagement solutions for retailers and product manufacturers, recently declared the Court has reset a Claim Construction Hearing, or “Markman hearing” for July 8, 2015 in the Eastern District of Texas for Blue Calypso’s patent infringement lawsuits against Groupon , Foursquare, Yelp (YELP) and IZEA. The hearing had been planned for Jun 29, 2015. Judge Rodney Gilstrap will preside.

Yelp Inc. operates a platform that connects people with local businesses in the United States. Its platform covers various local business categories, counting restaurants, shopping, beauty and fitness, arts, entertainment and events, home and local services, health, nightlife, travel and hotel, auto, and others categories.

Boeing Co (NYSE:BA)’s shares dropped -0.40% to $140.08.

Boeing Co (BA) released its 2015 Environment Report highlighting the company’s raised use of renewable energy, testing of environmentally promising technologies and other progress toward improving the environmental performance of its products, services and operations.

Highlights of the 2015 Report comprise:

Increasing use of renewable energy, counting powering the 4.3-million-square-foot 737 factory in Renton, Washington, with electricity from 100-percent renewable sources.

Testing more than 40 technologies on the ecoDemonstrator 787 and 757 to improve airplane fuel efficiency and reduce emissions and noise.

At the end of Tuesday’s trade, Oncothyreon Inc (USA) (NASDAQ:ONTY)‘s shares dipped -3.19% to $3.95.

Oncothyreon Inc. (ONTY) recently declared the presentation of positive data from the company’s ongoing trials of ONT-380, an orally active, reversible and selective small-molecule HER2 inhibitor for the treatment of breast cancer, at the American Society of Clinical Oncology (ASCO) 2015 Annual Meeting. The first presentation updated data from the Phase 1b trial of ONT-380 in combination with Xeloda(R) (capecitabine)and Herceptin(R) (trastuzumab) in third line treatment of HER2-positive metastatic breast cancer. The data support Oncothyreon’s plans to initiate a blinded, randomized, placebo-controlled Phase 2 trial in this indication. The second presentation focused on the role of ONT-380 in the treatment of HER2-positive breast cancer central nervous system (CNS) metastases.

Patients comprised of in the presentation on the role of ONT-380 in the treatment of CNS metastases were selected from the above trial and from an ongoing Phase 1b trial (ClinicalTrials.gov Identifier NCT01983501) of ONT-380 in combination with Kadcyla in patients who have been formerly treated with Herceptin and a taxane for metastatic breast cancer. Patients were comprised of if their presenting CNS lesions were evaluable for response using RECIST 1.1 criteria and they had either untreated, asymptomatic lesions having never received radiotherapy or surgery to the CNS (n=8) or new or progressive lesions following prior CNS therapy (n=14). Best CNS response was a CR in one patient, a PR in four patients and SD in nine patients. No patient had progressive disease as a CNS best response. One patient was not evaluable for response having undergone surgery for a symptomatic CNS lesion; pathologic examination of the resected specimen found no evidence of viable tumor. Two patients were not evaluated because of progressive disease outside of the CNS, while five patients in the series remain too early to evaluate.

Oncothyreon Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. Its clinical-stage product candidates comprise ONT-380, an orally active and selective small-molecule HER2 inhibitor, which is in two Phase 1b trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin; and ONT-10, a therapeutic vaccine in Phase 1 trial targeting the Mucin 1 peptide antigen (MUC1) for use in various cancer indications, counting breast, thyroid, colon, stomach, pancreas, ovarian, and prostate, in addition to certain types of lung cancer.

One of China’s largest cloud computing service providers, CU Cloud will bundle its services with Akamai’s offerings and both partners will further develop opportunities aimed at assisting Chinese businesses expand their web presence globally.

Akamai said the deal would extend the reach of its CDN (content delivery network) services in China. It added that CU Cloud also would be tapping its “turnkey CDN” technology to deliver its own cloud services.

Akamai Technologies, Inc. provides cloud services for delivering, optimizing, and securing online content and business applications in the United States and internationally. The company offers media content delivery solutions to execute digital media distribution strategies, counting download delivery solutions for the distribution of file downloads, such as games, progressive video and audio files, documents, and other file-based content; and adaptive delivery solutions for streaming video content in various bitrate streaming formats; content preparation and packaging for multiple platforms, a customizable media player, and content protection technologies; a suite of analytics tools to monitor online video viewer experiences and the effectiveness of Web software downloads, while measuring audience engagement, and quality of service performance; and NetStorage, a cloud storage solution.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.